Lord, Abbett & Co
OCDX

Lord, Abbett & Co’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Lord, Abbett & Co’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,294,119
Closed -$23.9M – 709
2021
Q3 		$23.9M Sell
1,294,119
-41,229
-3% -$830K 0.06% 387
2021
Q2 		$28.6M Buy
+1,335,348
New +$27.2M 0.07% 356

Other funds holding OCDX

CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Lord, Abbett & Co's OCDX Position: Q4 2021 in Review

Lord, Abbett & Co sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q4 2021, closing a stake of 1,294,119 shares — an estimated $23.9M sold.

Lord, Abbett & Co first reported a position in OCDX in Q2 2021 and held it in 2 quarters. The position peaked at $28.6M in Q2 2021. 162 funds tracked by Wall St. Rank hold OCDX as of Q4 2021.

  • Lord, Abbett & Co reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q4 2021 after selling out during the quarter.
  • Lord, Abbett & Co sold 1,294,119 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q4 2021, an estimated $23.9M.
  • Lord, Abbett & Co first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2021 and held it in 2 quarters.
  • Lord, Abbett & Co's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $28.6M in Q2 2021.
  • 162 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q4 2021.

Based on Lord, Abbett & Co's 13F filing for Q4 2021, filed 11 Feb 2022.